NASDAQ NMS - GLOBAL MARKET · GOVX
+7.97% · +$0.0480 · Vol 645.5K
Market closed · last close 4:00 PM ET · price as of 19:21:58 ET
GeoVax Labs Inc

GeoVax Labs Inc

Biotechnology
$0.6500
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
GOVX
GeoVax Labs Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

34/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GOVX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GOVX catalysts
About GeoVax Labs Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1995
Employees
19
Country
US

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.6294
Day high
$0.6590
Day low
$0.6125
Previous close
$0.6020
52W high
$19.57
-96.68% from high
52W low
$0.5947
0% of range
Market cap
$3.4M
EPS
$-0.9700
Beta
2.12
Shares out
5.2M
Volume
645.5K
0.97× rel vol
Avg volume
666.1K
VWAP
$0.6383
Price history computed in-house
1W
-9.47%
1M
-22.62%
3M
-82.14%
1Y
-96.61%
YTD
-84.80%
SMA 50 $0.9693 · below
SMA 200 $3.18 · below
52W position 0%

GOVX overview

Veridion Score
34
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GOVX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GOVX Form 4 filings
Public disclosures

Congress activity in GOVX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for GOVX in the cached public ledger.

Federal contracts

GOVX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GOVX in this window.
Lobbying spend

GOVX lobbying filings, year to date.

Registered lobbying filings matched to GeoVax Labs Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GOVX in this window.
Loading news for GOVX
Analyst ratings
Sovereign unlock shows live analyst consensus for GOVX.
Options
Sovereign unlock shows live options positioning for GOVX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.